Table of Content

1. Introduction



2. Research Methodology



3. Executive Summary



4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges


5. Global Smart Pills Market



6. Market Share
6.1 By Application
6.2 By Target Area
6.3 By End Users
6.4 By Country


7. Application
7.1 Capsule Endoscopy
7.2 Patient Monitoring
7.3 Drug Delivery


8. Target Area
8.1 Esophagus
8.2 Small Intestine
8.3 Large Intestine
8.4 Stomach


9. End Users
9.1 Diagnostic Centers
9.2 Hospitals
9.3 Research Institutes
9.4 Others


10. Country
10.1 North America

10.1.1 United States
10.1.2 Canada

10.2 Europe

10.2.1 France
10.2.2 Germany
10.2.3 Italy
10.2.4 Spain
10.2.5 United Kingdom
10.2.6 Belgium
10.2.7 Netherlands
10.2.8 Turkey

10.3 Asia Pacific

10.3.1 China
10.3.2 Japan
10.3.3 India
10.3.4 South Korea
10.3.5 Thailand
10.3.6 Malaysia
10.3.7 Indonesia
10.3.8 Australia
10.3.9 New Zealand

10.4 Latin America

10.4.1 Brazil
10.4.2 Mexico
10.4.3 Argentina

10.5 Middle East & Africa

10.5.1 Saudi Arabia
10.5.2 UAE
10.5.3 South Africa


11. Porter’s Five Analysis
11.1 Bargaining Power of Buyers
11.2 Bargaining Power of Suppliers
11.3 Degree of Rivalry
11.4 Threat of New Entrants
11.5 Threat of Substitutes


12. SWOT Analysis
12.1 Strength
12.2 Weakness
12.3 Opportunity
12.4 Threat


13. Company Analysis
13.1 Check-Cap Ltd.

13.1.1 Company Overview
13.1.2 Product Portfolio
13.1.3 Recent Developments/Updates
13.1.4 Financial Performance

13.2 General Electric Company

13.2.1 Company Overview
13.2.2 Product Portfolio
13.2.3 Recent Developments/Updates
13.2.4 Financial Performance

13.3 Fujifilm

13.3.1 Company Overview
13.3.2 Product Portfolio
13.3.3 Recent Developments/Updates
13.3.4 Financial Performance

13.4 Koninklijke Philips N.V.

13.4.1 Company Overview
13.4.2 Product Portfolio
13.4.3 Recent Developments/Updates
13.4.4 Financial Performance

13.5 Medtronic plc

13.5.1 Company Overview
13.5.2 Product Portfolio
13.5.3 Recent Developments/Updates
13.5.4 Financial Performance

13.6 Olympus Corporation

13.6.1 Company Overview
13.6.2 Product Portfolio
13.6.3 Recent Developments/Updates
13.6.4 Financial Performance

13.7 Novartis AG

13.7.1 Company Overview
13.7.2 Product Portfolio
13.7.3 Recent Developments/Updates
13.7.4 Financial Performance

13.8 Otsuka Holdings Co., Ltd.

13.8.1 Company Overview
13.8.2 Product Portfolio
13.8.3 Recent Developments/Updates
13.8.4 Financial Performance



List of Figures

0

List of Tables

0